Malignant Hyperthermia

2. Activate the medical emergency response system for clinical area and call ________hotline.
4. Ryanodex should be administered within ___ minutes of diagnosis.
5. ________ unexplained is another acute sign of MH.
7. Halothane ___________Contracture test is used to confirm MH.
10. MH is triggered by exposure to ___________ gases (Desflurane, Isoflurane, Sevoflurane, Haloflurane and succinylcholine)
11. each 250mg vial of Ryanodex must be reconstituted with ____ml sterile water for injection.
12. _____ for signs/symptoms of MH for 48 hrs (including vitals, muscle rigidity, dysrhythmias, cyanosis, tachypnea, rapid rising core temperature, cola colored urine)
13. MH Cart is located between the OR and _______.
15. first dose fo Ryanodex as 2.5mg/kg iv push ____ though a large bore IV is recommended.
16. Malignant hyperthermia is a rare __________ disorder.
18. The underlying cause is the intracellular release of ____________.
19. there are no _____-specific MH carts.

1. After the anesthesia provider notifies the surgeon of a possible MH crisis, the anesthesia provider should immediately ________ use of all volatile agents.
3. _________ is a formulation of dantolene that can be reconstituted and used for a MH crisis at CCUH.
6. Anesthesia breathing system connects the patient’s airway to the anesthetic machine creating an _________ atmosphere.
7. _______ saline is available in the anesthesia work room refrigerator and pharmacy.
8. A high risk patient for MH is a ___ degree relative of anyone known to MHS or have a positive muscle biopsy.
9. Acute sign of MH is unexplained _____ muscle rigidity.
11. For any patient that is susceptible to MH the OR should obtain a clean _________ ABS and exchange the existing ABS.
14. MH is characterized by sever hyper-metabolic state and ____ of the skeletal muscles.
17. any non-stimulating _______ anesthetic can be used on a MH susceptible patient.